Document Detail


Validation of a prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: moving toward individualized treatment decision-making.
MedLine Citation:
PMID:  18668546     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: The decision to start disease-modifying antirheumatic drugs in patients with recent-onset undifferentiated arthritis (UA) is complicated by a varied natural disease course in which the disease in one-third of patients progresses to rheumatoid arthritis (RA), whereas 40-50% of patients experience spontaneous remission. Recently, a prediction rule was developed to estimate the chance of progression to RA in individual patients presenting with UA. This study investigates the accuracy of this prediction rule in independent cohorts of patients with UA.
METHODS: In 3 cohorts of patients with recent-onset UA, from the UK, Germany, and The Netherlands, the prediction score and the corresponding chance of developing RA were calculated. These data were compared with the observed disease outcome after > or =1 year of followup. Positive predictive values (PPVs) and negative predictive values (NPVs) were calculated and the overall discriminative ability of the prediction rule was assessed using area under the receiver operating characteristic curves (AUCs).
RESULTS: Since data on the severity of morning stiffness were not available in all validation cohorts, the prediction rule was rederived with the duration of morning stiffness as a substitute. The AUC for this rule was 0.88 (SEM 0.015). For each validation cohort, the AUC was 0.83 (SEM 0.041), 0.82 (SEM 0.037), and 0.95 (SEM 0.031) in the British, German, and Dutch cohorts, respectively. The NPV (for a prediction score < or =6) in these 3 cohorts was 83%, 83%, and 86%, respectively; the PPV (for a prediction score > or =8) was 100%, 93%, and 100%, respectively.
CONCLUSION: The recently derived prediction rule, when applied to 3 independent cohorts of patients with UA, has an excellent discriminative ability for assessing the likelihood of progression to RA. Application of this rule will allow individualized treatment decision-making for patients with UA.
Authors:
Annette H M van der Helm-van Mil; Jacqueline Detert; Saskia le Cessie; Andrew Filer; Hans Bastian; Gerd R Burmester; Tom W J Huizinga; Karim Raza
Related Documents :
8456646 - Are antibodies reactive with chondrocyte proteins enriched in synovial fluids of patien...
10599346 - Incidence of antiperinuclear factor in patients with psoriatic arthritis.
20436076 - Predictors of clinical response and radiographic progression in patients with rheumatoi...
1294736 - Sex hormones and bone metabolism in postmenopausal rheumatoid arthritis treated with tw...
2872866 - Thallium-technetium parathyroid scan. a useful noninvasive technique for localization o...
15986976 - A retroperitoneal bleed induced by enoxaparin therapy.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Validation Studies    
Journal Detail:
Title:  Arthritis and rheumatism     Volume:  58     ISSN:  0004-3591     ISO Abbreviation:  Arthritis Rheum.     Publication Date:  2008 Aug 
Date Detail:
Created Date:  2008-08-07     Completed Date:  2008-09-18     Revised Date:  2011-12-01    
Medline Journal Info:
Nlm Unique ID:  0370605     Medline TA:  Arthritis Rheum     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2241-7     Citation Subset:  AIM; IM    
Affiliation:
Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands. AvdHelm@lumc.nl <AvdHelm@lumc.nl>
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antirheumatic Agents / therapeutic use
Arthritis / diagnosis*,  drug therapy
Arthritis, Rheumatoid / epidemiology
Cohort Studies
Decision Support Techniques*
Disease Progression
Female
Germany
Great Britain
Humans
Male
Middle Aged
Netherlands
Prognosis
Risk Factors
Severity of Illness Index
Grant Support
ID/Acronym/Agency:
//Arthritis Research UK
Chemical
Reg. No./Substance:
0/Antirheumatic Agents
Comments/Corrections
Comment In:
Arthritis Rheum. 2009 May;60(5):1565; author reply 1565   [PMID:  19404977 ]
Arthritis Rheum. 2009 Mar;60(3):905; author reply 906   [PMID:  19248101 ]
Erratum In:
Arthritis Rheum. 2008 Oct;58(10):3276

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Raldh expression in embryos of the direct developing frog Eleutherodactylus coqui and the conserved ...
Next Document:  Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, tran...